Back to Top
Charles H. Hood Foundation | Nurture Genomics
By identifying innovative pediatric advancements and providing funding in the critical phases of development, we are able to expedite high-impact breakthroughs that improve the health and lives of millions.
portfolio_page-template-default,single,single-portfolio_page,postid-18707,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

Program Related Investment

Nurture Genomics

Every year, millions of American children face the challenges of undiagnosed genetic conditions. Staggeringly, over 10.8 million children in the United States, aged 0 to 17, live with a genetic condition. Despite the availability of advanced medical technology, only a mere 2% of these conditions are detected early, with approximately 12,000 cases identified through state-run newborn screening programs. These screenings currently fail to cover over 700 treatable genetic conditions, leaving a significant gap as thousands of new treatments emerge in the drug discovery pipeline.


Founded in 2022, Nurture Genomics Inc. bridges the gap between knowledge and impact, providing parents and healthcare providers with meaningful health insights based on cutting-edge genomic science. Led by clinical geneticists, researchers, and genetic counselors, Nurture Genomics puts genomic science into practice. We offer genome sequencing for healthy babies and children, facilitating early diagnosis and timely access to life-changing medical interventions. Learn more.